1. Home
  2. KRMD vs OXLCO Comparison

KRMD vs OXLCO Comparison

Compare KRMD & OXLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$6.10

Market Cap

288.6M

Sector

Health Care

ML Signal

HOLD

Logo Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

OXLCO

Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

HOLD

Current Price

$23.56

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
OXLCO
Founded
1980
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
288.6M
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KRMD
OXLCO
Price
$6.10
$23.56
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.88
N/A
AVG Volume (30 Days)
194.4K
N/A
Earning Date
11-12-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
N/A
Revenue This Year
$23.36
N/A
Revenue Next Year
$18.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.12
N/A
52 Week Low
$1.86
N/A
52 Week High
$6.61
N/A

Technical Indicators

Market Signals
Indicator
KRMD
OXLCO
Relative Strength Index (RSI) 60.91 57.47
Support Level $5.48 $23.37
Resistance Level $6.61 $23.54
Average True Range (ATR) 0.32 0.10
MACD -0.01 0.01
Stochastic Oscillator 53.94 53.19

Price Performance

Historical Comparison
KRMD
OXLCO

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Share on Social Networks: